Marion HealthCare, LLC. v. Becton Dickinson & Company

952 F.3d 832
CourtCourt of Appeals for the Seventh Circuit
DecidedMarch 5, 2020
Docket18-3735
StatusPublished
Cited by20 cases

This text of 952 F.3d 832 (Marion HealthCare, LLC. v. Becton Dickinson & Company) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Marion HealthCare, LLC. v. Becton Dickinson & Company, 952 F.3d 832 (7th Cir. 2020).

Opinion

In the

United States Court of Appeals For the Seventh Circuit ____________________ No. 18-3735 MARION HEALTHCARE, LLC, et al., Plaintiffs-Appellants, v.

BECTON DICKINSON & COMPANY, et al., Defendants-Appellees. ____________________

Appeal from the United States District Court for the Southern District of Illinois. No. 3:18-cv-01059-NJR-RJD — Nancy J. Rosenstengel, Chief Judge. ____________________

ARGUED SEPTEMBER 27, 2019 — DECIDED MARCH 5, 2020 ____________________

Before WOOD, Chief Judge, and KANNE and BARRETT, Circuit Judges. WOOD, Chief Judge. Since the Supreme Court’s decision in Illinois Brick v. Illinois, 431 U.S. 720 (1977), only those buyers who purchased products directly from the antitrust violator have a claim against that party for treble damages. “Indirect purchasers” who paid too much for a product because cartel or monopoly overcharges were passed on to them by middle- men must take their lumps and hope that the market will 2 No. 18-3735

eventually sort everything out. See, e.g., Sharif Pharm., Inc. v. Prime Therapeutics, LLC, Nos. 18-2725 and 18-3003, 2020 WL 881267 at *2 (7th Cir. Feb. 24, 2020). Matters are different, how- ever, when a monopolist enters into a conspiracy with its dis- tributors. In such cases, “the first buyer from a conspirator is the right party to sue.” Paper Sys. Inc. v. Nippon Paper Indus. Co., 281 F.3d 629, 631 (7th Cir. 2002). The plaintiffs in this case (“the Providers”) are healthcare companies that purchased medical devices manufactured by Becton Dickinson & Company. Healthcare providers often do not purchase medical devices directly from the manufacturer; instead, they join a group purchasing organization, known in the trade as a GPO. The GPO negotiates prices with the man- ufacturer on behalf of its members. It then presents the terms to the provider, which has the opportunity to accept them or reject them. If the provider agrees to the terms, it chooses a distributor to deliver the product. The distributor then enters into contracts with the healthcare provider and the manufac- turer. These contracts obligate the distributor to procure the products from the manufacturer and to sell them to the pro- vider. The distribution contracts with the providers incorpo- rate the price and other terms of the agreements that the GPO negotiated, plus a markup for the chosen distributor. Our Providers purchased medical devices in the manner just described. A GPO negotiated with Becton on the Provid- ers’ behalf, and a distributor delivered the devices. Had Bec- ton acted alone, selling its products to an independent distrib- utor, which then sold them to a healthcare provider, no one doubts that the Illinois Brick rule would bar the provider from suing Becton for any alleged monopoly overcharges. But these transactions were more complex. The Providers allege No. 18-3735 3

that Becton, the GPOs, and the distributors (to whom we refer collectively as Becton unless the context requires otherwise) joined forces in a conspiracy and engaged in a variety of anti- competitive measures, including exclusive-dealing and pen- alty provisions. Becton moved to dismiss, arguing that the Il- linois Brick rule barred the case despite the Providers’ allega- tions of conspiracy. The district court agreed with Becton that the Illinois Brick rule applied on these facts and that dismissal was therefore required. It found the conspiracy rule inapplicable not be- cause of any failure to plead conspiracy adequately, but be- cause this case did not involve simple vertical price-fixing. This, we conclude, was in error. At the same time, we con- clude that as of now the Providers have failed adequately to allege the necessary conspiracy with the distributors, and per- haps with the GPOs. Because the district court’s ruling de- pended so heavily on an error of law relating to Illinois Brick, we have decided to vacate the court’s decision and remand for further proceedings. I We present the facts in the light most favorable to the Pro- viders without vouching for anything. Each of the Providers has purchased conventional syringes, safety syringes, and safety IV catheters from Becton. They allege that Becton charges supracompetitive prices for these products. It is able to do so, they assert, because it has monopoly power in the relevant nationwide market and is unlawfully maintaining that power through anticompetitive contract arrangements among itself, the GPOs, and the distributors. 4 No. 18-3735

In order to accomplish its goals, Becton took several steps. The first addressed its relationship to the GPOs. Although the GPOs are supposed to negotiate at arms’ length, with their members’ best interests in mind, Becton ensured that their loyalty would run to Becton, by bribing them with millions of dollars annually in so-called administrative fees to include anticompetitive terms in the contract. These terms include penalty pricing for healthcare providers who fail to purchase a certain amount of their devices from Becton. Second, the Providers allege that the distributor agreements prop up the unfair terms of the contracts that the GPOs negotiate. Third, they allege that the agreements between Becton and the dis- tributors include hidden commitments to make payments to the GPOs based on the volume of Becton products sold under the contracts. Becton pays distributors for selling more of its products, and in return, the distributors agree to promote Bec- ton products above the products of competitors. The Provid- ers allege that this network of contracts allows Becton to charge prices well above those of its competitors. Following industry practice, the Providers did not buy di- rectly from Becton. They relied upon the GPO system de- scribed above, unaware of the distortions Becton had intro- duced. The distributors purchased the medical devices from Becton at the rates negotiated by the GPOs, and the Providers then purchased the devices from the distributors. Because they did not purchase directly from Becton, the Providers may pursue Becton itself only if they have properly alleged a conspiracy. II Section 4 of the Clayton Act states that “any person who shall be injured in his business or property by reason of No. 18-3735 5

anything forbidden in the antitrust laws may sue therefor,” and is entitled to treble damages for the violation. 15 U.S.C. § 15. In this instance, however, the words “any person” can- not be taken literally. Instead, the Supreme Court has read them in the context of the statute as a whole and has inferred that certain limitations exist. One such limitation was an- nounced in Illinois Brick, where the Court held that, in general, a downstream plaintiff cannot sue an alleged monopolist or cartel member on a theory that a middleman passed an anti- competitive overcharge on to her. Under Illinois Brick, only a purchaser who purchased goods directly from the monopolist (or cartel member) can claim damages. That purchaser is en- titled to the full value of the damages stemming from the overcharge, even if it passed on some or all of the overcharge to downstream purchasers and consequently mitigated the damage it suffered. See Hanover Shoe, Inc. v. United Shoe Ma- chinery Corp., 392 U.S. 481 (1968). A plaintiff who asserts that it indirectly bore the brunt of an overcharge passed on by the direct purchaser has no claim. The Supreme Court based its decision in Illinois Brick on several rationales.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
952 F.3d 832, Counsel Stack Legal Research, https://law.counselstack.com/opinion/marion-healthcare-llc-v-becton-dickinson-company-ca7-2020.